Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 174, Issue 11, 2006, Pages 1211-1220

  Kraemer, Richard ^a   Deloséa, Natascha ^b   Ballinari, Pietro ^b   Gallati, Sabina ^b   Crameri, Reto ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b NONE

Author keywords

Allergic bronchopulmonary aspergillosis; Aspergillus fumigatus sensitization; Cystic fibrosis; Lung function; Pseudomonas aeruginosa infection

Indexed keywords

IMMUNOGLOBULIN E;

ADOLESCENT; ADULT; AIRWAY RESISTANCE; ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIAL COLONIZATION; BRONCHOPULMONARY ASPERGILLOMA; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE COURSE; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; GRAM NEGATIVE INFECTION; HUMAN; LUNG CLEARANCE; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ADOLESCENT; ALLERGENS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; CHILD; CHRONIC DISEASE; COMORBIDITY; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE PROGRESSION; FEMALE; FUNGAL PROTEINS; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; PSEUDOMONAS INFECTIONS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 33845542156     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200603-423OC     Document Type: Article

References (44)

1. Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002;110:685-692.
2. Greenberger PA. Allergic bronchopulmonary aspergillosis and fungoses. Clin Chest Med 1988;9:599-608.
3. Geller DE, Kaplowitz H, Light MJ, Colin AA. Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Scientific Advisory Group, Investigators, and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Chest 1999;116:639-646.
4. Mastella G, Rainisio M, Harms HK, Hodson ME, Koch C, Navarro J, Strandvik B, McKenzie SG. Allergic bronchopulmonary aspergillosis in cystic fibrosis: a European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. Eur Respir J 2000;16:464-471.
5. el-Dahr JM, Fink R, Selden R, Arruda LK, Platts-Mills TA, Heymann PW. Development of immune responses to Aspergillus at an early age in children with cystic fibrosis. Am J Respir Crit Care Med 1994;150:1513-1518.
6. Slavin RG. ABPA in CF: a devastating combination. Pediatr Pulmonol 1996;21:1-2.
7. Chauhan B, Santiago L, Kirschmann DA, Hauptfeld V, Knutsen AP, Hutcheson PS, Woulfe SL, Slavin RG, Schwartz HJ, Bellone CJ. The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis. J Immunol 1997;159:4072-4076.
8. Miller PW, Hamosh A, Macek M Jr, Greenberger PA, MacLean J, Walden SM, Slavin RG, Cutting GR. Cystic fibrosis transmembrane conductance regulator (CFTR) genemutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet 1996;59:45-51.
9. Marchand E, Verellen-Dumoulin C, Mairesse M, Delaunois L, Brancaleone P, Rahier JF, Vandenplas O. Frequency of cystic fibrosis transmembrane conductance regulator gene mutations and 5T allele in patients with allergic bronchopulmonary aspergillosis. Chest 2001;119:762-767.
10. Chauhan B, Santiago L, Hutcheson PS, Schwartz HJ, Spitznagel E, Castro M, Slavin RG, Bellone CJ. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2000;106:723-729.
11. Levitz SM. Overview of host defenses in fungal infections. Clin Infect Dis 1992;14:S37-S42.
12. Romani L. The T cell response against fungal infections. Curr Opin Immunol 1997;9:484-490.
13. Skov M, Poulsen LK, Koch C. Increased antigen-specific Th-2 response in allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis. Pediatr Pulmonol 1999;27:74-79.
14. Slavin RG, Hutcheson PS, Chauhan B, Bellone CJ. An overview of allergic bronchopulmonary aspergillosis with some new insights. Allergy Asthma Proc 2004;25:395-399.
15. Stevens DA, Moss RB, Kurup VP, Knutsen AP, Greenberger P, Judson MA, Denning DW, Crameri R, Brody AS, Light M, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis: state of the art. Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003;37:S225-S264.
16. Nicolai T, Arleth S, Spaeth A, Bertele-Harms RM, Harms HK. Correlation of IgE antibody titer to Aspergillus fumigatus with decreased lung function in cystic fibrosis. Pediatr Pulmonol 1990;8:12-15.
17. Wojnarowski C, Eichler I, Gartner C, Gotz M, Renner S, Koller DY, Frischer T. Sensitization to Aspergillus fumigatus and lung function in children with cystic fibrosis. Am J Respir Crit Care Med 1997;155:1902-1907.
18. Hogaboam CM, Carpenter KJ, Schuh JM, Buckland KF. Aspergillus and asthma: any link? Med Mycol 2005;43:S197-S202.
19. Kraemer R, Deloséa N, Ballinari P, Gallati S, Crameri R. Effect of allergic broncho-pulmonary aspergillosis (ABPA) on progression of lung function in children with cystic fibrosis. J Cyst Fibros 2006;5:S53.
20. Kraemer R, Blum A, Schibler A, Ammann RA, Gallati S. Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis. Am J Respir Crit Care Med 2005;171:371-378.
21. Liechti-Gallati S, Schneider V, Neeser D, Kraemer R. Two buffer PAGE system-based SSCP/HD analysis: a general protocol for rapid and sensitive mutation screening in cystic fibrosis and any other human genetic disease. Eur J Hum Genet 1999;7:590-598.
22. Hemmann S, Nikolaizik WH, Schoni MH, Blaser K, Crameri R. Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy. Eur J Immunol 1998;28:1155-1160.
23. Crameri R, Hemmann S, Ismail C, Menz G, Blaser K. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis. Int Immunol 1998;10:1211-1216.
24. Casaulta C, Fluckiger S, Crameri R, Blaser K, Schoeni MH. Time course of antibody response to recombinant Aspergillus fumigatus antigens in cystic fibrosis with and without ABPA. Pediatr Allergy Immunol 2005;16:217-225.
25. Aebi C, Bracher R, Liechti-Gallati S, Tschappeler H, Rudeberg A, Kraemer R. The age at onset of chronic Pseudomonas aeruginosa colonization in cystic fibrosis - prognostic significance. Eur J Pediatr 1995;154(9 Suppl 4)S69-S73.
26. Nelson LA, Callerame ML, Schwartz RH. Aspergillosis and atopy in cystic fibrosis. Am Rev Respir Dis 1979;120:863-873.
27. Nikolaizik WH, Weichel M, Blaser K, Crameri R. Intracutaneous tests with recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis and Aspergillus allergy. Am J Respir Crit Care Med 2002;165:916-921.
28. Crameri R. Recombinant Aspergillus fumigatus allergens: from the nucleotide sequences to clinical applications. Int Arch Allergy Immunol 1998;115:99-114.
29. Kraemer R, Zehnder M, Meister B. Intrapulmonary gas distribution in healthy children. Respir Physiol 1986;65:127-137.
30. Zapletal A, Samanek M, Paul T. Lung function in children and adolescents. Basel, Switzerland: Karger; 1987.
31. Manzke H, Stadlober E, Schellauf HP. Combined body plethysmographic, spirometric and flow volume reference values for male and female children aged 6 to 16 years obtained from "hospital normals". Eur J Pediatr 2001;160:300-306.
32. Steiner B, Truninger K, Sanz J, Schaller A, Gallati S. The role of common single-nucleotide polymorphisms on exon 9 and exon 12 skipping in nonmutated CFTR alleles. Hum Mutat 2004;24:120-129.
33. Corey M, Edwards L, Levison H, Knowles M. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J Pediatr 1997;131:809-814.
34. Edwards LJ. Modern statistical techniques for the analysis of longitudinal data in biomedical research. Pediatr Pulmonol 2000;30:330-344.
35. Schonheyder H, Jensen T, Hoiby N, Andersen P, Koch C. Frequency of Aspergillus fumigatus isolates and antibodies to Aspergillus antigens in cystic fibrosis. Acta Pathol Microbiol Immunol Scand [B] 1985;93:105-112.
36. Skov M, Pressler T, Jensen HE, Hoiby N, Koch C. Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA). Thorax 1999;54:44-50.
37. Hemmann S, Menz G, Ismail C, Blaser K, Crameri R. Skin test reactivity to 2 recombinant Aspergillus fumigatus allergens in A fumigatus-sensitized asthmatic subjects allows diagnostic separation of allergic bronchopulmonary aspergillosis from fungal sensitization. J Allergy Clin Immunol 1999;104:601-607.
38. Nikolaizik WH, Crameri R, Blaser K, Schoni MH. Skin test reactivity to recombinant Aspergillus fumigatus allergen I/a in patients with cystic fibrosis. Int Arch Allergy Immunol 1996;111:403-408.
39. Almeida MB, Bussamra MH, Rodrigues JC. ABPA diagnosis in cystic fibrosis patients: the clinical utility of IgE specific to recombinant Aspergillus fumigatus allergens. J Pediatr (Rio J) 2006;82:215-220.
40. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 1998;132:589-595.
41. Kurup VP, Knutsen AP, Moss RB, Bansal NK. Specific antibodies to recombinant allergens of Aspergillus fumigatus in cystic fibrosis patients with ABPA. Clin Mol Allergy 2006;4:11.
42. Hartl D, Latzin P, Zissel G, Krane M, Krauss-Etschmann S, Griese M. Chemokines indicate allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Am J Respir Crit Care Med 2006;173:1370-1376.
43. Nikolaizik WH, Moser M, Crameri R, Little S, Warner JO, Blaser K, Schoni MH. Identification of allergic bronchopulmonary aspergillosis in cystic fibrosis patients by recombinant Aspergillus fumigatus I/a-specific serology. Am J Respir Crit Care Med 1995;152:634-639.
44. Graves TS, Fink JN, Patterson R, Kurup VP, Scanlon GT. A familial occurrence of allergic bronchopulmonary aspergillosis. Ann Intern Med 1979;91:378-382.